Arrive AI (ARAI) Q2 2025 earnings summary

Executive summary

• Achieved first commercial revenue in Q2 2025, marking a transition from R&D to operational deployments and commercial execution.

• Completed Nasdaq listing in May 2025, incurring significant one-time expenses and expanding the investor base via crowdfunding.

• Entered strategic partnerships and pilots with Hancock Health, Go2 Delivery, Skye Air Mobility, and others, expanding market reach in healthcare, retail, and logistics.

• Issued new patents, bringing total to eight, and expanded equity incentive plans to support growth and talent retention.

• Emphasized a five-year plan targeting scalable manufacturing, recurring revenue, and a tenfold increase in enterprise value.

Financial highlights

• Q2 2025 revenue was $90,725, the first in company history, primarily from consulting, installation, and subscription services.

• Net loss for Q2 2025 was $4.69 million, mainly due to $3 million in one-time public listing costs; adjusted net loss was $1.35 million, comparable to prior periods.

• Cash at quarter-end was $607,000, up from $129,318 at year-end, with nearly full access to a $40 million capital facility.

• Operating expenses rose to $6.18 million from $1.48 million year-over-year, driven by listing costs and higher compensation.

• Weighted-average shares outstanding increased to 31.5 million for Q2 2025.

Outlook and guidance

• Five-year plan aims for a 10x increase in enterprise value, with annual production scaling to 10,000 units by year four and 100,000 by year five.

• Revenue mix targeted to be evenly split between Arrive Points network and AI platform services, with growth expected from data monetization and platform fees.

• Capital runway expected to last through 2027, with additional funding anticipated as manufacturing scales.

• Plans to triple team size in Q3, focusing on AI, engineering, and operations.

• Focused on scaling production for international deployment and advancing edge AI analytics.